MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $956,776 | -11.8% | 208,448 | -4.9% | 0.00% | -20.0% |
| Q1 2023 | $1,085,317 | +9.9% | 219,256 | +21.3% | 0.01% | 0.0% |
| Q4 2022 | $987,218 | +51.4% | 180,809 | +80.4% | 0.01% | +25.0% |
| Q3 2022 | $652,000 | – | 100,254 | +196476.5% | 0.00% | – |
| Q2 2022 | $0 | – | 51 | +37.8% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 37 | -78.4% | 0.00% | – |
| Q3 2021 | $2,000 | – | 171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
| NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
| Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
| Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
| RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
| APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
| Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
| Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
| First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
| Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |